Clement Louise, Boylan Mallory, Miller Virginia G, Rockwell Mary, Allred Kendra
South Plains Kidney Disease Center, Lubbock, Texas 79416, USA.
J Ren Nutr. 2007 Sep;17(5):343-9. doi: 10.1053/j.jrn.2007.05.007.
The purpose of this study was to evaluate if there was a significant difference in serum and RBC folate or serum cobalamin levels in depressed and nondepressed subjects on hemodialysis (HD).
A cross-sectional design was used in this study. Each subject's serum folate and cobalamin, and red blood cell (RBC) folate were measured. The Beck Depression Index II (BDI-II) was used to assess for depression. Subjects with scores of 10 or greater were considered depressed. Other laboratory, anthropometric, and demographic data were obtained from the subjects' medical records. To assess for significant differences (P < 0.05) in the laboratory values of the outcome variables between depressed and nondepressed subjects, t tests were performed on the groups' mean values.
The study was conducted with patients in two dialysis centers in Texas.
Seventy-three individuals undergoing HD for at least six months who met study inclusion criteria were solicited to participate in the study after the study was approved by the respective institutional review board.
Depression and mental status of each subject were assessed using the BDI-II and the Folstein Mini-Mental State Exam, respectively.
Serum folate, cobalamin, total homocysteine, and RBC folate were measured and mean values were evaluated for significant differences in the depressed and nondepressed groups.
Of the subjects in this study, 43.8% had BDI-II scores > 10 indicating depression. The nondepressed subjects had significantly higher mean serum folate (281 +/- 649 vs. 52 +/- 137 ng/mL), serum cobalamin (1162 +/- 1014 vs. 757 +/- 463 pg/mL), and RBC folate (1433 +/- 1757 vs. 810 +/- 654 ng/mL) levels than did depressed subjects. In the nondepressed group, 39% of subjects were taking a supplement containing 35-42 mg folacin and 7 mg cobalamin per week while only 9.1% of depressed subjects were taking a vitamin containing these levels of B vitamins. The group means were not significantly different for age, months on HD, body mass index, erythropoietin/kg body weight, total homocysteine, hemoglobin, albumin, or ferritin.
As with the general population, lower serum folate, RBC folate, and serum cobalamin levels were found in depressed as compared to nondepressed subjects on HD. Plasma levels of these vitamins may be one of many factors related to depression, but larger studies with stronger designs are needed to confirm the results of this study.
本研究旨在评估接受血液透析(HD)的抑郁与非抑郁患者在血清和红细胞叶酸或血清钴胺素水平上是否存在显著差异。
本研究采用横断面设计。测量了每位受试者的血清叶酸、钴胺素以及红细胞(RBC)叶酸水平。使用贝克抑郁量表第二版(BDI-II)评估抑郁情况。得分在10分及以上的受试者被视为抑郁。其他实验室、人体测量学和人口统计学数据从受试者的病历中获取。为评估抑郁与非抑郁受试者在结果变量实验室值上的显著差异(P < 0.05),对两组均值进行了t检验。
该研究在得克萨斯州的两个透析中心对患者进行。
在研究获得各自机构审查委员会批准后,招募了73名接受HD至少六个月且符合研究纳入标准的个体参与研究。
分别使用BDI-II和福尔斯坦简易精神状态检查表评估每位受试者的抑郁和精神状态。
测量血清叶酸、钴胺素、总同型半胱氨酸和RBC叶酸,并评估抑郁组与非抑郁组均值的显著差异。
本研究中的受试者,43.8%的BDI-II得分>10,表明存在抑郁。非抑郁受试者的血清叶酸(281±649 vs. 52±137 ng/mL)、血清钴胺素(1162±1014 vs. 757±463 pg/mL)和RBC叶酸(1433±1757 vs. 810±654 ng/mL)水平显著高于抑郁受试者。在非抑郁组中,39%的受试者每周服用含35 - 42 mg叶酸和7 mg钴胺素的补充剂,而抑郁受试者中只有9.1%服用含这些水平B族维生素的维生素。两组在年龄、HD时长、体重指数、促红细胞生成素/体重、总同型半胱氨酸、血红蛋白、白蛋白或铁蛋白方面的均值无显著差异。
与普通人群一样,接受HD的抑郁受试者与非抑郁受试者相比,血清叶酸、RBC叶酸和血清钴胺素水平较低。这些维生素的血浆水平可能是与抑郁相关的众多因素之一,但需要设计更严谨的更大规模研究来证实本研究结果。